NasdaqCM - Nasdaq Real Time Price USD

Gyre Therapeutics, Inc. (GYRE)

11.09 +0.33 (+3.07%)
At close: June 7 at 4:00 PM EDT
11.10 +0.01 (+0.09%)
After hours: June 7 at 5:56 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS -2.40.15----

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts 1--11
Avg. Estimate 113.45M--113.45M--
Low Estimate --------
High Estimate --------
Year Ago Sales ----794k113.45M
Sales Growth (year/est) ----14,188.40%--

Earnings History

CURRENCY IN USD 9/30/2022 3/31/2023 6/30/2023 9/30/2023
EPS Est. -1.5-1.05-1.05-0.75
EPS Actual -2.40.15-1.05-1.05
Difference -0.91.20-0.3
Surprise % -60.00%114.30%0.00%-40.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate 0000
7 Days Ago -0.60-2.4-0.45
30 Days Ago -0.60-2.4-0.45
60 Days Ago -0.60-2.4-0.45
90 Days Ago -0.60-2.4-0.45

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD GYREIndustrySectorS&P 500
Current Qtr. ------8.30%
Next Qtr. ------10.70%
Current Year ------4.90%
Next Year ------12.50%
Next 5 Years (per annum) -23.33%----11.23%
Past 5 Years (per annum) --------

Research Analysis

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Related Tickers